Page 133 - The Drucker Lectures
P. 133

114 [   The Drucker Lectures

                       that’s the only place where we have results. But maybe it would
                       be a good idea if I at least were forced to think about it. And
                       when the employee or the employee group comes back to you,
                       don’t say “yes” immediately, and don’t say “no.” It is your right
                       and your duty to approve or not to approve the goals, but think
                       it through.
                          Let me say that the appraisal needs to start out against preset
                       targets. Now, nine times out of ten, when 18 months later you sit
                       down and look at how this person has performed, you will find
                       that the goals have changed—that three weeks into the year, you
                       called him in and said, “Joe, we have an urgency,” or “The plan
                       was based on your obtaining new equipment, and you didn’t get
                       it.” Still, at least one knows what one deviates from.
                          The next thing to say is that once the employee has thought
                       through his or her performance and comes to you for a critique,
                       focus on achievement and contribution before you focus on non-
                       performance. The impairments, the bad habits, the areas of ig-
                       norance, the things where improvement is needed—they will all
                       come out. You will not have to point them out. You might say,
                       “You may be a little too harsh on yourself here.” Or: “This is quite
                       a respectable performance. But in this area, I think you take it a
                       little bit too easy. This is important, and it’s not good enough just
                       to get by.” And so put the burden of setting objectives and of ap-
                       praising against them on the individual or the group.
                          To be clear: There are some areas where you’ll have to ad-
                       dress a group. For example, it is almost impossible to evaluate in-
                       dividuals in a research department because so much of the work
                       is a team effort. At a pharmaceutical company, the initial stages
                       of pure research are largely individual. But then you get to the
                       stage of developing a class of compounds. And there you have
                       the biochemist and the pharmacologist and the medical people
                       and so on, and you’re really talking about a team. In that case,
                       one sits down every three years, perhaps, and says, “What have
   128   129   130   131   132   133   134   135   136   137   138